SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-324905
Filing Date
2019-12-27
Accepted
2019-12-27 17:15:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d858098dsc13d.htm SC 13D 35810
2 EX-99.1 d858098dex991.htm EX-99.1 26264
  Complete submission text file 0001193125-19-324905.txt   63520
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88050 | Film No.: 191314122
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Filed by) CIK: 0001588467 (see all company filings)

Type: SC 13D